Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 86,600 | 62,471 | 68,179 | 59,321 | 67,122 |
| Cost of Goods | 66,475 | 56,674 | 45,462 | 42,203 | 47,616 |
| Gross Profit | 20,125 | 5,797 | 22,717 | 17,118 | 19,506 |
| Operating Expenses | 17,688 | 16,206 | 18,097 | 9,856 | 13,156 |
| Operating Income | 2,912 | -9,735 | 5,082 | 7,465 | 6,966 |
| Interest Expense | 2,701 | 2,575 | 3,065 | 2,616 | 1,149 |
| Other Income | -238 | 235 | -192 | -40 | 50 |
| Pre-tax Income | -27 | -12,075 | 1,825 | 4,809 | 5,867 |
| Income Tax | 1,834 | -3,434 | -1,899 | 1,309 | 1,831 |
| Net Income Continuous | -1,861 | -8,641 | 3,724 | 3,500 | 4,036 |
| Net Income | $-1,861 | $-8,641 | $3,724 | $3,500 | $4,036 |
| EPS Basic Total Ops | -0.06 | -0.27 | 0.12 | 0.11 | 0.13 |
| EPS Basic Continuous Ops | -0.06 | -0.27 | 0.12 | 0.11 | 0.13 |
| EPS Diluted Total Ops | -0.05 | -0.27 | 0.11 | 0.11 | 0.12 |
| EPS Diluted Continuous Ops | -0.05 | -0.27 | 0.11 | 0.11 | 0.13 |
| EBITDA(a) | $8,460 | $-4,451 | $10,078 | $11,527 | $12,743 |